Clinical Trial: REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Cancer
Study Type: INTERVENTIONAL
Official Title: REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
Brief Summary:
To learn about the effects of the investigational drug NKTR-255 in combination with the standard drug durvalumab on locally advanced NSCLC when given after CRT.
Read more